Key2Brain is a Swedish biotechnology company dedicated to developing next generation brain targeting therapies utilizing its proprietary blood-brain barrier-crossing technology. The technology enables efficient brain uptake and broad distribution into the brain and can be integrated into a wide range of therapeutic molecules. The pipeline is being developed internally and in partnerships where Key2Brain’s team leverages extensive industry experience in biologics and brain-targeting drugs, accelerating the translation from discovery to the clinic.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Stockholm, Se
- Industry
- Biotechnology
- Website
- http://www.key2brain.com
- HQ
- Stockholm
Key2brain Ab Questions
Key2Brain Ab's website is http://www.key2brain.com
Key2Brain Ab's LinkedIn profile is https://se.linkedin.com/company/key2brain-ab
Key2Brain Ab has
9 employees.
View email and phone details for 9
employees at Key2Brain Ab.
Key2Brain Ab's industry is
Biotechnology
Key2Brain Ab's top competitors are
Basic Genomics Ab,
Xpress Genomics,
Aax Biotech Ab,
Elysian Biologics,
Chiesi Group,
Lsi Epsilon,
Inossia Ab,
Brainzell,
Countagen,
Navinci.
Key2Brain Ab's categories are Biotechnology
Key2Brain Ab's founding year is 2020
